Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies

PURPOSE: To determine the long-term efficacy of the anti-tumor necrosis factor (TNF) agents, infliximab (IFX) and adalimumab (ADA), in pediatric luminal Crohn's disease (CD) by performing a systematic literature review. METHODS: An electronic search was performed in Medline, Embase, and the Coc...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rheenen, Hanna, van Rheenen, Patrick Ferry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2020
Materias:
Systemic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073369/
https://www.ncbi.nlm.nih.gov/pubmed/32206624
http://dx.doi.org/10.5223/pghn.2020.23.2.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073369/
https://www.ncbi.nlm.nih.gov/pubmed/32206624
http://dx.doi.org/10.5223/pghn.2020.23.2.121

Ejemplares similares